A high-profile case escalated to the Supreme Court seeks to limit the nationwide access to the abortion pill mifepristone via telemedicine and mail, following a lawsuit by Louisiana claiming the FDA's 2021 policy allowing such measures violates state sovereignty and lacks sufficient review. #AbortionRights #Telemedicine #SupremeCourt #US #LA #TX


